These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23105099)

  • 21. Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1.
    Li M; Naidu P; Yu Y; Berger NA; Kannan P
    Biochem J; 2004 Aug; 382(Pt 1):323-9. PubMed ID: 15170387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment.
    Oplustilova L; Wolanin K; Mistrik M; Korinkova G; Simkova D; Bouchal J; Lenobel R; Bartkova J; Lau A; O'Connor MJ; Lukas J; Bartek J
    Cell Cycle; 2012 Oct; 11(20):3837-50. PubMed ID: 22983061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diindolylmethane-mediated Gli1 protein suppression induces anoikis in ovarian cancer cells in vitro and blocks tumor formation ability in vivo.
    Kandala PK; Srivastava SK
    J Biol Chem; 2012 Aug; 287(34):28745-54. PubMed ID: 22773833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNKS1BP1 functions in DNA double-strand break repair though facilitating DNA-PKcs autophosphorylation dependent on PARP-1.
    Zou LH; Shang ZF; Tan W; Liu XD; Xu QZ; Song M; Wang Y; Guan H; Zhang SM; Yu L; Zhong CG; Zhou PK
    Oncotarget; 2015 Mar; 6(9):7011-22. PubMed ID: 25749521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
    Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
    Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.
    Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J
    Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage.
    Yang F; Zhao N; Wu N
    Mol Med Rep; 2017 Sep; 16(3):2962-2968. PubMed ID: 28677724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
    He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
    Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-4 enhances PARP-dependent DNA repair activity in vitro.
    Ciszewski WM; Wagner W; Kania KD; Dastych J
    J Interferon Cytokine Res; 2014 Sep; 34(9):734-40. PubMed ID: 24724620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways.
    Liu X; Han EK; Anderson M; Shi Y; Semizarov D; Wang G; McGonigal T; Roberts L; Lasko L; Palma J; Zhu GD; Penning T; Rosenberg S; Giranda VL; Luo Y; Leverson J; Johnson EF; Shoemaker AR
    Mol Cancer Res; 2009 Oct; 7(10):1686-92. PubMed ID: 19825992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest.
    Lundholm L; Hååg P; Zong D; Juntti T; Mörk B; Lewensohn R; Viktorsson K
    Cell Death Dis; 2013 Jan; 4(1):e478. PubMed ID: 23370278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer.
    Boerner JL; Nechiporchik N; Mueller KL; Polin L; Heilbrun L; Boerner SA; Zoratti GL; Stark K; LoRusso PM; Burger A
    PLoS One; 2015; 10(3):e0119614. PubMed ID: 25774912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
    Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
    Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting poly (ADP) ribose polymerase I (PARP-1) and PARP-1 interacting proteins for cancer treatment.
    Sakamoto-Hojo ET; Balajee AS
    Anticancer Agents Med Chem; 2008 May; 8(4):402-16. PubMed ID: 18473725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates.
    Li S; Zhou Y; Wang R; Zhang H; Dong Y; Ip C
    Mol Cancer Ther; 2007 Mar; 6(3):1031-8. PubMed ID: 17339365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
    Nasser MW; Datta J; Nuovo G; Kutay H; Motiwala T; Majumder S; Wang B; Suster S; Jacob ST; Ghoshal K
    J Biol Chem; 2008 Nov; 283(48):33394-405. PubMed ID: 18818206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin induces early embryo apoptosis by inhibiting poly(ADP ribose) polymerase.
    Wang QL; Sun SC; Han J; Kwak YC; Kim NH; Cui XS
    In Vivo; 2012; 26(5):827-34. PubMed ID: 22949597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
    Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
    Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
    Lin PH; Lin CH; Huang CC; Chuang MC; Lin P
    Toxicol Lett; 2007 Aug; 172(3):146-58. PubMed ID: 17669606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer.
    Meng F; Zhang H; Liu G; Kreike B; Chen W; Sethi S; Miller FR; Wu G
    Neoplasia; 2011 May; 13(5):472-82. PubMed ID: 21532888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.